Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Jazz Pharmaceuticals will pay $57 million as part of a tentative deal with the U.S. Department of Labor to settle an investigation into the drugmaker's donations to patient assistance charities, reports Bloomberg.
Takeda Pharmaceutical Co. plans to acquire its much larger rival Shire for $62 billion in cash and stock by Jan. 8 — a deal that would catapult the Japanese company into a new league of drug industry giants, according to a Reuters…
The FDA posted a supply shortage alert for EpiPens and other epinephrine auto-injectors May 9, after patients and pharmacists in 45 states reported it was difficult to find the lifesaving allergic reaction treatment.
Software issues constituted the No. 1 reason for U.S. medical device recalls for the eighth consecutive quarter, according to a recent analysis of 2018 first-quarter recall data.
In a move to distance itself from past controversies involving drug price increases, Valeant Pharmaceuticals will change its name to Bausch Health Cos., according to The Wall Street Journal.
New gene therapies designed to cure hemophilia could cost $1.5 million or more, according to a May 7 Leerink analyst note cited by CNBC.
The FDA on May 4 approved Novartis' combination therapy to treat an aggressive form of thyroid cancer.
Wilson-Cook Medical on May 7 earned FDA clearance for its product Hemospray, which is designed to help control bleeding in the gastrointestinal tract.
The president of Regional Health Rapid City (S.D.) Hospital said the hospital is taking additional steps to ensure its medical waste is being disposed of properly after city officials alleged last week the institution has continued to dump medical waste…
A Maine bill that aims to increase drug pricing transparency became law on April 30, according to a STAT report.